search
Back to results

Outcomes to the Nutritional Need of Patients With Parkinson's Disease (W-Domus)

Primary Purpose

Deglutition Disorders, Parkinson Disease, Nursing

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
weancare-domus
Sponsored by
Milko Zanini
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Deglutition Disorders

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • clinical diagnosis of FOIS-based disphagy or Smithard test (3 oz swallow test) (2 - 3) or previous FEES diagnosis
  • classification of the functional oral intake scale (FOIS) level of disphagy in classes 4 or 5 (or levels 2-3 on specific clinical indication)
  • Belonging to one of the territorial structures for the Management of Parkinson's Disease in the territory of Genoa

Exclusion Criteria:

  • Terminally ill subjects for pathology
  • Subjects with severe disphagia and indication to artificial nutrition (enteral/parenteral)
  • Severe renal, liver and respiratory failure
  • Disphagy level classifications inconsistent with inclusion criteria

Sites / Locations

  • ASL 3 Genovese Struttura Complessa Recupero e Rieducazione Funzionale Ospedale "La Colletta" Via del Giappone, 5 - Arenzano (GE)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

intervention

control

Arm Description

The participating subjects belonging to the experimental group, will receive at home a set of foods with modified textures that allow the patient to feed for the observation period of 4 months, will also be followed by the dietary service of the center and by personnel identified within the protocol in order to verify compliance, liability and information regarding the evaluation scales involved in the project.

The control group will continue with its own feeding for the entire observation period of the experimental group.

Outcomes

Primary Outcome Measures

Non-motor symptomatology change (Novel Non-Motor Symptoms Scale for Parkinson's Disease - NNMS)
Novel Non-Motor Symptoms Scale for Parkinson's Disease includes 9 domains and 30 items. Each symptom scored with respect to: Severity: 0 = None, 1 = Mild: symptoms present but causes little distress or disturbance to patient; 2 = Moderate: some distress or disturbance to patient; 3 = Severe: major source of distress or disturbance to patient. Frequency: 1 = Rarely (<1/wk); 2 = Often (1/wk); 3 = Frequent (several times per week); 4 = Very Frequent (daily or all the time).

Secondary Outcome Measures

Suction and ab-ingestis events related to textured food change (Novel Non-Motor Symptoms Scale for Parkinson's Disease - Domain 6: Gastrointestinal tract)
Novel Non-Motor Symptoms Scale for Parkinson's Disease - Domain 6: Gastrointestinal tract includes 3 items. Each symptom scored with respect to: Severity: 0 = None, 1 = Mild: symptoms present but causes little distress or disturbance to patient; 2 = Moderate: some distress or disturbance to patient; 3 = Severe: major source of distress or disturbance to patient. Frequency: 1 = Rarely (<1/wk); 2 = Often (1/wk); 3 = Frequent (several times per week); 4 = Very Frequent (daily or all the time). 19. Does the patient dribble saliva during the day? 20. Does the patient have difficulty swallowing? 21. Does the patient suffer from constipation? (Bowel action less than three times weekly)

Full Information

First Posted
June 9, 2021
Last Updated
September 27, 2021
Sponsor
Milko Zanini
Collaborators
Azienda Sanitaria Locale 3 Genovese
search

1. Study Identification

Unique Protocol Identification Number
NCT04983290
Brief Title
Outcomes to the Nutritional Need of Patients With Parkinson's Disease
Acronym
W-Domus
Official Title
Clinical Trial to Assess the Effectiveness of the Food Plan Consisting of Products With Modified Consistency Called (Weancare-Domus) in Changing the Quality of Life in Patients With Parkinson's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2021 (Anticipated)
Primary Completion Date
December 31, 2021 (Anticipated)
Study Completion Date
May 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Milko Zanini
Collaborators
Azienda Sanitaria Locale 3 Genovese

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The intervention involves the identification of 140 patients (70 per group), fed throughout the duration of the study with the two different solutions indicated. The subject will be interviewed by identified and trained personnel in order to collect the information and data required by the study with frequency indicated for the individual evaluation sheets. The subject himself will be provided with all the contact and availability information of the referents of the firm for the purpose of requesting information or reporting events. The subject in the studio will be contacted weekly in order to evaluate the trend by the study referents, according to his availability, and personally interviewed by staff belonging to the research group.
Detailed Description
Non-motor symptomatology in Parkinson's disease (PD) is related to the quality of life of patients . Malnutrition in the subject with Parkinson's is a still relevant variable that hesitates in sarcopenia and increased motor deficits in relation to loss of muscle mass and energy deficit. Guidelines from the European Society for Clinical Nutrition and Metabolism (ESPEN) recommend monitoring and implementing interventions in the presence of weight loss or body mass. Disphagia is a syndrome common in Parkinson's patients, even in the early stages of the pathology. The study by Pflug and collaborators showed that only 5% of the patients observed were completely free from swallowing deficiency, while in 55% of subjects (66/119) aspiration or penetration of food and liquids in the airways were reported regardless of the stage of illness. Several studies, cited by Curtis and collaborators, show that the prevalence of disphagia varies between 11 and 97% of patients during the course of the disease. This condition affects both food safety, with the risk of aspiration and ab-ingestis, and malnutrition conditions, hydration deficiency, also affecting the overall survival of patients in relation to the onset of pneumonia. From a nursing point of view, great interest has the integrated nutritional indices, easy and quick-to-use tools, which manage to determine promptly the presence and risk of malnutrition and which can be used daily in the patient's evaluation. The most suitable is the Mini Nutritional Assessment (MNA), which determines the risk of malnutrition before modification of biochemical parameters. MNA has a sensitivity of 96% and a specificity of 97%. The adoption of scales that evaluate non-motorcycle-related symptoms helps to identify the sindromic dimension of the pathology, highlighting its components that impact the overall quality of life. Patients who follow a level 3 and 4 modified texture diet of the IDDSI Framework scheme frequently encounter an overall reduction in energy and protein intake, determined by the way the meal is prepared in self-production, associated with an often drastic reduction in fluid intake with consequences in both systemic and specific terms for the gastrointestinal tract. Monitoring liquids introduced by subjects with swallowing deficiency is a Grade B recommendation in the ESPEN guidelines. Disphagia is a frequent condition in the subject with Parkinson's disease, particularly in the advanced stages, recent studies begin to show a decay in the safety of swallowing and maintenance in the airway in these subjects, even in relatively early stages of the disease. Therefore, the application of a specific nutritional program for patients with swallowing problems is recommended in the prevention of malnutrition in patients with Parkinson's disease. Previous studies showed the rapid reversibility of malnutrition in hospitalized elderly subjects with cognitive and functional impairment if enrolled in a specific nutritional program. In view of the strong impact that eating difficulties have on the state of health of parkinson's disease patients suffering from disphagia, the widespread spread of dietary frailties related to the various degrees of disphagia and the importance that patients with slight difficulty swallowing or chewing do not develop further pathologies related to a nutritional deficit , it is necessary to study the effectiveness of specific nutritional programs developed to meet the person's need for nutrition The aim of the study is to improve the nursing-care management of Parkinson's disease patients with disphagia

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Deglutition Disorders, Parkinson Disease, Nursing, Quality of Life

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Randomized nutraceutical clinical trial controlled with cross-over design on two groups
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
140 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
intervention
Arm Type
Experimental
Arm Description
The participating subjects belonging to the experimental group, will receive at home a set of foods with modified textures that allow the patient to feed for the observation period of 4 months, will also be followed by the dietary service of the center and by personnel identified within the protocol in order to verify compliance, liability and information regarding the evaluation scales involved in the project.
Arm Title
control
Arm Type
No Intervention
Arm Description
The control group will continue with its own feeding for the entire observation period of the experimental group.
Intervention Type
Dietary Supplement
Intervention Name(s)
weancare-domus
Intervention Description
Participants belonging to the experimental group will receive at home a set of foods that allows to receive the right amount of proteins and energy in a modified texture form to be prepared by themselves or by their caregivers
Primary Outcome Measure Information:
Title
Non-motor symptomatology change (Novel Non-Motor Symptoms Scale for Parkinson's Disease - NNMS)
Description
Novel Non-Motor Symptoms Scale for Parkinson's Disease includes 9 domains and 30 items. Each symptom scored with respect to: Severity: 0 = None, 1 = Mild: symptoms present but causes little distress or disturbance to patient; 2 = Moderate: some distress or disturbance to patient; 3 = Severe: major source of distress or disturbance to patient. Frequency: 1 = Rarely (<1/wk); 2 = Often (1/wk); 3 = Frequent (several times per week); 4 = Very Frequent (daily or all the time).
Time Frame
4 months
Secondary Outcome Measure Information:
Title
Suction and ab-ingestis events related to textured food change (Novel Non-Motor Symptoms Scale for Parkinson's Disease - Domain 6: Gastrointestinal tract)
Description
Novel Non-Motor Symptoms Scale for Parkinson's Disease - Domain 6: Gastrointestinal tract includes 3 items. Each symptom scored with respect to: Severity: 0 = None, 1 = Mild: symptoms present but causes little distress or disturbance to patient; 2 = Moderate: some distress or disturbance to patient; 3 = Severe: major source of distress or disturbance to patient. Frequency: 1 = Rarely (<1/wk); 2 = Often (1/wk); 3 = Frequent (several times per week); 4 = Very Frequent (daily or all the time). 19. Does the patient dribble saliva during the day? 20. Does the patient have difficulty swallowing? 21. Does the patient suffer from constipation? (Bowel action less than three times weekly)
Time Frame
4 months
Other Pre-specified Outcome Measures:
Title
functional parameter related to malnutrition change: Gait speed
Description
Gait speed in metres per second (m/s): the fastest gait speed in 4 metres after 3 trials was recorded. Patients may use an assistive device, if needed.
Time Frame
4 months
Title
functional parameter related to malnutrition change: grip strength
Description
grip strength of the hand in kg: Handgrip strength will assess using a hydraulic dynamometer. The participant will be seated, resting his or her arm on the chair arms and instructed to squeeze the dynamometer as hard as possible, with the highest score of the 3 trials recorded
Time Frame
4 months
Title
functional parameter related to malnutrition change: muscle mass
Description
muscle mass index (%) will be evaluate by Bioelectrical Impedance Analysis (BIA)
Time Frame
4 months
Title
functional parameter related to malnutrition change: Body Mass Index (BMI)
Description
weight in kg, height in cm (weight and height will be combined to report BMI in Kg/m^2)
Time Frame
4 months
Title
functional parameter related to malnutrition change: arm circumference
Description
arm circumference in cm
Time Frame
4 months
Title
functional parameter related to malnutrition change: biomarkers
Description
plasma cholinesterase concentration (U/ml)
Time Frame
4 months
Title
functional parameter related to malnutrition change: biomarkers
Description
plasma transferrin concentration (mg/dL)
Time Frame
4 months
Title
functional parameter related to malnutrition change: biomarkers
Description
plasma albumin concentration (g/dL)
Time Frame
4 months
Title
functional parameter related to malnutrition change: immunological indices
Description
lymphocyte count in 1 microliter (µL) of blood
Time Frame
4 months
Title
functional parameter related to malnutrition change: Nutritional status evaluation
Description
• phase angle and derived body composition data: Phase angle is a linear method of measuring the relationship between electric resistance (R) and reactance (Rc) in series or parallel circuits. It reflects cellular vitality and integrity, where normal values indicate preserved cellular activity. It is an important tool in assessing nutritional status in any situation, being superior to anthropometric and biochemical methods.
Time Frame
4 months
Title
functional parameter related to malnutrition change: Nutritional status evaluation - MNA score
Description
Mini Nutritional Assessment Score (MNA):Mini Nutritional Assessment score (MNA) is probably the most widely used and best validated score in different elderly populations and settings. The tool consists of a 6-item short form screening tool (MNA-SF) included in the 18-item long form scale (MNA-LF). From 24 to 30 points: Normal nutritional status; from 17 to 23.5 points: At risk of malnutrition; Less than 17 points: Malnourished
Time Frame
4 months
Title
functional parameter related to malnutrition change: Bolus transit time evaluation
Description
time of complete capture of the bolus and the reflex firing of swallowing in minutes
Time Frame
4 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: clinical diagnosis of FOIS-based disphagy or Smithard test (3 oz swallow test) (2 - 3) or previous FEES diagnosis classification of the functional oral intake scale (FOIS) level of disphagy in classes 4 or 5 (or levels 2-3 on specific clinical indication) Belonging to one of the territorial structures for the Management of Parkinson's Disease in the territory of Genoa Exclusion Criteria: Terminally ill subjects for pathology Subjects with severe disphagia and indication to artificial nutrition (enteral/parenteral) Severe renal, liver and respiratory failure Disphagy level classifications inconsistent with inclusion criteria
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Annamaria Bagnasco, Prof
Phone
+3901035385
Email
annamaria.bagnasco@unige.it
First Name & Middle Initial & Last Name or Official Title & Degree
Milko Zanini, Dr
Phone
+3901035385
Email
milko.zanini@edu.unige.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marina Simonini, Dr
Organizational Affiliation
Asl 3 genovese
Official's Role
Principal Investigator
Facility Information:
Facility Name
ASL 3 Genovese Struttura Complessa Recupero e Rieducazione Funzionale Ospedale "La Colletta" Via del Giappone, 5 - Arenzano (GE)
City
Genova
ZIP/Postal Code
16132
Country
Italy
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marina Simonini, PI
Phone
+390108498067
Email
Marina.Simonini@asl3.liguria.it
First Name & Middle Initial & Last Name & Degree
Antonella Giusti, I
Phone
+390108498067
Email
Antonella.Giusti@asl3.liguria.it

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Outcomes to the Nutritional Need of Patients With Parkinson's Disease

We'll reach out to this number within 24 hrs